Ignite Creation Date:
2025-12-24 @ 11:56 PM
Ignite Modification Date:
2025-12-25 @ 9:53 PM
Study NCT ID:
NCT05670951
Status:
RECRUITING
Last Update Posted:
2025-05-28
First Post:
2023-01-02
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Efficacy and Safety of ELGN-2112 on Intestinal Malabsorption in Preterm Infants
Sponsor:
Elgan Pharma Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-02-20
Start Date Type:
ACTUAL
Primary Completion Date:
2027-11
Primary Completion Date Type:
ESTIMATED
Completion Date:
2029-05
Completion Date Type:
ESTIMATED
First Submit Date:
2023-01-02
First Submit QC Date:
None
Study First Post Date:
2023-01-04
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-05-22
Last Update Post Date:
2025-05-28
Last Update Post Date Type:
ACTUAL